4:25 pm Roundtable Discussion: Optimizing Patient Selection to Improve MASH Trial Outcomes for Global Treatment Success
Time: 4:25 pm
day: Conf Day 1
Details:
- Emphasizing the necessity of incorporating non-invasive tests (NITs) to complement or potentially replace liver biopsies in MASH clinical trials, especially in global settings, to improve patient comfort, reduce screening failures, and enhance the feasibility of large-scale studies
- Highlighting the importance of addressing the heterogeneity of MASH across different ethnicities and geographical regions by employing tailored patient selection strategies that account for genetic variations, environmental factors, and regional disparities in disease presentation
- Discussing the need for collaborative efforts among researchers, clinicians, regulatory agencies, and industry stakeholders to establish standardized patient selection criteria and promote the inclusion of diverse populations in MASH clinical trials, ultimately leading to more generalizable and effective treatments
